People conflate it with heart disease. Underwriters do not. And that distinction is usually good news.
Last reviewed September 2026 by Dev Gaymes, Texas-licensed life insurance agent, NPN 16654074 · Editorial policy
Atrial fibrillation affects millions of adults and becomes considerably more common after 60. Most people who have it assume it lands them in the same category as a heart attack. It does not. AFib is an electrical rhythm problem rather than a blockage problem, and underwriters assess it separately. Usually more favourably than applicants expect.
The first question an underwriter asks is not how often you have episodes. It is whether there is structural heart disease underneath.
General industry patterns, not any single carrier's guidelines. The echocardiogram is usually the document that determines which column you are in.
General industry patterns. Individual outcomes depend on your full cardiac picture and the carrier's guidelines when you apply.
Postponement periods and rate class outcomes described here reflect general industry practice across multiple carriers as of September 2026; they are not any single insurer’s published guidelines and change over time. Texas policy forms and rates are filed with the Texas Department of Insurance. Dev Gaymes is a licensed Texas producer, NPN 16654074, verifiable through the NIPR national producer database.
Usually yes, and often at better rates than expected. AFib is an electrical rhythm problem rather than a blockage problem, and underwriters assess it separately from coronary artery disease. Someone with paroxysmal AFib, a structurally normal heart, controlled ventricular rate and appropriate anticoagulation can realistically reach Standard, and some carriers go better than that.
No, and this is the most useful thing to know. The first question an underwriter asks is whether there is structural heart disease underneath. Valve disease, cardiomyopathy, a prior heart attack or heart failure. Lone AFib with a structurally normal heart is assessed on the arrhythmia and stroke risk alone. AFib alongside structural disease is assessed primarily on that underlying condition, which is a materially different file.
Generally no - it usually helps. Anticoagulation indicates that stroke risk associated with AFib is being actively managed, which is what underwriters want to see. Declining anticoagulation where a physician recommended it reads considerably worse than taking it. Never adjust an anticoagulant for an insurance application; prescription databases show your history regardless and the medical risk is real.
Your most recent echocardiogram. It answers the question that decides the file. Whether there is structural heart disease. An echo showing normal chamber size, normal ejection fraction and no valve disease puts you in the favourable category. Applicants frequently have this report and do not think to provide it, which leaves the underwriter ordering records and assuming nothing in the meantime.
Often yes. A successful ablation with sustained sinus rhythm afterwards generally strengthens the file, and outcomes after twelve months of documented sinus rhythm are frequently better than before the procedure. Carriers typically want six to twelve months post-ablation before assessing, so applying immediately afterwards usually results in a postponement rather than an offer.
Yes, though less than people assume. Paroxysmal AFib. Episodes that begin and end on their own. Is generally viewed more favourably than persistent or permanent AFib. But rate control matters more than rhythm: well-rate-controlled permanent AFib can produce a better outcome than poorly controlled paroxysmal AFib. What the underwriter is pricing is the risk of stroke and heart failure, not the label.
They are assessed together, and the association is well recognised, untreated obstructive sleep apnea is closely linked to atrial fibrillation. The useful news is that documented CPAP compliance strengthens both files at once. If you have AFib and have never been evaluated for sleep apnea, that is worth raising with your physician, because untreated apnea alongside AFib is a more conservative file than either alone.
That changes the assessment materially and is evaluated separately from the AFib itself. Carriers commonly apply a postponement period after a stroke or TIA before considering an application, and the outcome afterwards depends on the extent of recovery, the cause, and whether anticoagulation is now in place. Coverage is frequently still available, but it is a different conversation and carrier selection matters considerably more.
Dev Gaymes is a licensed insurance broker, not a physician. General education, not medical advice and not advice about your situation, and not an offer of insurance or a quote. Never change, start or stop any medication or treatment for an insurance application or for any reason other than your physician’s direction. Underwriting guidelines - including postponement periods, rate classes and thresholds. Vary by carrier, product and state, change over time, and are applied case by case at the underwriter’s discretion. Nothing here describes any particular insurer’s current guidelines or predicts your outcome. All coverage is subject to carrier underwriting approval, and policy terms, benefits, exclusions and limitations are governed solely by the issued policy contract. Always answer every application question completely and truthfully.
Bring your recent TSH results and how long you've been on the same dose. In most cases this is a straightforward file.
Prefer to talk now? Call 214-989-7704